EQS Group-Media / 2020-01-23 / 19:00
*Media Release*
*Medacta Announces Several First-time Surgeries and CE Marking for Multiple
Products for its Sports Medicine Division*
_CASTEL SAN PIETRO_, _23 January 2020_ - Medacta is proud to announce the
successful completion of several first-time surgeries in the United States
and Australia.
Over the last few weeks, Dr. Wesley Cox from Fayetteville, Arkansas,
performed several glenoid labral repairs in the shoulder using Medacta's
MectaLock PEEK labral anchors. Dr. Cox is the first surgeon worldwide to use
the Medacta instability anchor in shoulder labral repair.
After the introduction of the first hip labral repair surgeries in Australia
with Dr. Parminder Singh using the Medacta MectaLock Peek Hip labral repair
anchor, Dr. Michael B. Gerhardt performed the same surgery in Santa Monica,
California, in December using Medacta's complete hip portfolio. Dr. Gerhardt
used Medacta's MectaLock PEEK anchor together with MectaFlip Intra Articular
Expander, Medacta Hip Cannula System and the newly launched Hip Access Kit.
Dr. Gerhardt's words after his first case were: "Using Medacta's new hip
anchors and Mectaflip was a very positive experience. Congratulations to
Medacta, I think we are building an excellent portfolio."
On the other side of the globe, in Sydney, Australia, Dr. Bu Balalla
performed an ACL reconstruction using Medacta's Adjustable Button for the
first time both on the femoral and tibial side. This was the first time the
Adjustable Button had been used on the tibia. Earlier Adjustable Button
surgeries on the femur had been carried out by Dr. Akbar Nawab, Louisville,
Kentucky and Dr. Matteo Denti, Lugano, Switzerland.
Furthermore, Medacta is particularly proud to announce it has recently
received CE marking for multiple sports medicine products: MectaLock PEEK
instability anchors for hip and shoulder labral repair, MectaLock Ti and
MectaTap for rotator cuff repair, MectaScrew PEEK interference screw for
ligament repairs, Medacta Shoulder and Hip Cannula System, MectaQTH
quadriceps tendon harvesting instrument and the Medacta Hip Access KIT for
hip arthroscopies.
The launch of these new products and the recent first-time surgeries in the
United States and Australia clearly show Medacta's commitment to continue
developing its sports medicine portfolio, which consists of minimally
invasive procedures aimed at allowing patients to return quickly to daily
activities.
Discover more at sportsmed.medacta.com
*Contact*
Medacta International SA
Gianluca Olgiati
Senior Director Global Marketing
Phone: +41 91 696 60 60
media@medacta.ch
*About Medacta*
Medacta is an international company specializing in the design and
production of innovative orthopaedic products and the development of
accompanying surgical techniques for joint replacement, spine surgery, and
sports medicine. Established in 1999 in Switzerland, Medacta's products and
surgical techniques are characterized by innovation. Medacta is a pioneer in
developing new offerings based upon minimally invasive surgical techniques,
in particular its Anterior Minimally Invasive Surgery ("AMIS") technique for
hip replacements. Medacta has leveraged its orthopaedic expertise and
comprehensive understanding of the human body to develop the sophisticated
"MySolutions" technology, which offers surgeons highly personalized
pre-operative planning and implant placement methodologies by creating
advanced personalized kinematic models and 3D planning tools for use in hip,
knee, shoulder and spine procedures.
Issuer: Medacta Group SA
Key word(s): Advertisement/Communication
End of Corporate News
Language: English
Company: Medacta Group SA
Strada Regina
6874 Castel San Pietro
Switzerland
Phone: +41 91 696 6060
E-mail: info@medacta.ch, investor.relations@medacta.ch
Internet: www.medacta.com
ISIN: CH0468525222
Listed: SIX Swiss Exchange
EQS News ID: 960109
End of News EQS Group Media
960109 2020-01-23
(END) Dow Jones Newswires
January 23, 2020 13:00 ET (18:00 GMT)
© 2020 Dow Jones News
